James Whittle


I help life sciences innovators build their intellectual property from their first patent application up to complex international patent portfolios, positioning them for fund raising, product launch, or acquisition and guiding them through due diligence.


Dr. James Whittle advises gene therapy, cell therapy, and genomics companies in building and acquiring patent portfolios with an eye towards investor diligence, life cycle management, and ANDA or BPCIA litigation.

Download full bio 


  • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies 

  • Cooley advises Zymergen on patent matters surrounding $400 million landmark agtech deal 


  • The George Washington University Law School
    JD, Highest Honors, Order of the Coif, 2016

  • Massachusetts Institute of Technology
    PhD, Biology, National Science Foundation Graduate Fellow

  • Harvard College
    AB, Chemistry
    magna cum laude, 2003

Admissions & Credentials

Registered to practice before the United States Patent & Trademark Office (USPTO)

District of Columbia



  • American Bar Association

  • American Intellectual Property Law Association

  • The George Washington University Law School Intellectual Property & Technology Law Advisory Council